Recovering From Intimate Partner Violence Through Strengths and Empowerment (RISE): Tailoring and Evaluating a Patient-Centered Counseling Intervention for Women Veterans
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 60
- Locations
- 2
- Primary Endpoint
- Empowerment Via the Personal Progress Scale Revised
Study Overview
Brief Summary
Intimate partner violence (IPV) is a major health concern for women Veterans. IPV is associated with numerous physical and mental health conditions. VHA is implementing IPV screening programs to identify female patients who experience past-year IPV. Despite strong evidence that screening increases detection of IPV, less is established about how to intervene following IPV disclosure in health care settings, in order to improve health outcomes. Existing healthcare-based interventions result in minimal effects on health and well-being, likely because they are too brief and generic.
In response, the PI has developed Recovering from IPV through Strengths and Empowerment (RISE), based on the IPV-related health care needs and preferences of women Veterans. RISE is designed to be delivered in primary care and is an individualized, variable-length, modular-based intervention that addresses
- safety planning;
- education on the health effects of IPV and warning signs;
- increasing coping skills and self-care;
- enhancing social support;
- making difficult decisions; and
- connecting with resources. This study is aimed at refining and evaluating RISE for use with female VA patients who have experienced past-year IPV. This brief counseling intervention is intended to be administered in conjunction with primary care, as this is a frequent point of healthcare contact for women Veterans and where disclosure of IPV is most prevalent.
Detailed Description
Women are the fastest growing group of VHA patients, with their population recently increasing by 80%. Women Veterans (WV's) are at higher risk for IPV than their non-Veteran peers, with that 1 in 3 WVs report lifetime IPV, compared to 1 in 4 women in the general U.S. population. Research reports up to 30% of WVs experience past-year IPV. As a result, WVs are considered an important population for IPV screening and counseling interventions. In response, VHA Women's Health Services (WHS) and the IPV Assistance Program of Care Management and Social Work Services (CMSWS) are implementing IPV screening programs for women and are seeking an effective intervention to implement into care. Extant brief counseling interventions for IPV result in minimal effects on patients' health and safety. A recent review of IPV screening trials highlighted insufficient intensity of post-disclosure counseling interventions, concluding that existing interventions are too brief, unstructured, and generic. Such minimal intervention effects of the current standard of care have led leaders in the field to call for the development and testing of new and more comprehensive IPV interventions, especially for delivery in conjunction with primary care. The Recovering from IPV through Strengths and Empowerment (RISE) intervention fills this need.
The PI, a clinical psychologist and health services researcher with expertise in and national recognition for IPV research and care, has developed an innovative IPV intervention to respond to this need. Recovering from IPV through Strengths and Empowerment (RISE) is based on the healthcare needs and preferences of WVs who have experienced IPV. RISE was developed using rigorous methods, building on the evidence base from the applicant's HSR&D CDA and on input of VHA primary care and behavioral health experts. RISE is based on empowerment, a highly relevant intervention model for women who experience IPV. It is an individualized, variable-length, modular-based intervention addressing key factors:
- safety planning,
- educating about the health effects of IPV and warning signs,
- improving coping and self-care,
- enhancing social support,
- making difficult decisions, and
- connecting with resources. RISE is rooted in empowerment and incorporates aspects of Motivational Interviewing, an evidence-based approach designed to facilitate behavior change that is widely used in VHA for numerous health issues.
This timely research project addresses the critical gap in current IPV care. It will refine and formally evaluate RISE using established methods for rapid and efficient effectiveness testing, including a Hybrid 1 randomized clinical trial (RCT) to evaluate RISE that simultaneously gathers information on barriers to and facilitators of implementation. The study is guided by the first two phases of the Replicating Effective Programs (REP) framework, pre-conditions and pre-implementation. These phases emphasize tailoring interventions with stakeholder input and iterative cycles of pilot testing within routine practice conditions. Use of the REP framework will maximize the likelihood that RISE-should its effectiveness be demonstrated-can easily be integrated into routine care in VHA.
The Specific Aims of this study are as follows:
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Masking Description
Open label
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Participants will be eligible to participate if they:
- •Self-identify as a woman
- •Are at least 18 years of age
- •A patient at VA Boston Healthcare System
- •Self- reported that they have experienced past-year physical, sexual, or psychological IPV
- •Ability to understand study procedures in English
- •Not exhibiting symptoms of mania or psychosis
- •Not actively in suicidal crisis warranting imminent hospitalization
Exclusion Criteria
- •Any violation of inclusion criteria
Outcomes
Primary Outcomes
Empowerment Via the Personal Progress Scale Revised
Time Frame: Baseline,10-week follow-up, and 14-week follow-up assessments
Measures change in sense of personal empowerment; minimum value = 28 and maximum score = 196; higher scores indicate higher personal empowerment
Patient Activation Measure (PAM-13)
Time Frame: Baseline, 10-week follow-up, and 14-week follow-up assessments
Measures change in patient engagement in needed health care; scores are transferred to a theoretical 0-100 scale; higher scores indicate higher patient activation.
Valued Living Questionnaire
Time Frame: Baseline, 10-week follow-up, and 14-week follow-up assessments
Measures change in valued living, and congruence between stated values and past-week valued behavior; Composite scores range from 10 (minimum) to 100 (maximum). Higher scores reflect higher valued living (i.e., an indicator of higher quality of life)
Self-efficacy Via the General Self-Efficacy Scale
Time Frame: Baseline, 10-week follow-up, and 14-week follow-up assessments
This scale is a self-report of change in general self-efficacy; minimum score = 4 and maximum score = 40; higher scores indicate higher self-efficacy
Secondary Outcomes
- Conflict Tactic Scales Revised(Baseline, 10-week follow-up, and 14-week follow-up assessments)
- Client Services Questionnaire (CSQ-8)(10-week follow-up assessment)
- Patient Health Questionnaire(Baseline, 10-week follow-up, and 14-week follow-up assessments)
- PTSD Checklist for DSM-5(Baseline, 10-week follow-up, and 14-week follow-up assessments)
- Center for Epidemiological Studies-Depression Scale(Baseline, 10-week follow-up, and 14-week follow-up assessments)
- SF-12 Health Survey(Baseline, 10-Week follow-up, and 14-Week follow-up Assessments)
- Physical, Mental and Social Service Care Use(Baseline, 10-week follow-up, and 14-week follow-up assessments)
- Connor-Davidson Resilience Scale(Baseline, 10-week follow-up, and 14-week follow-up assessments)
- Safety Behaviors Checklist(Baseline, 10-week follow-up, and 14-week follow-up assessments)
- Depression Anxiety Stress Scale- Anxiety Subscale(Baseline, 10-week follow-up, and 14-week follow-up assessments)
- Coping Strategies Inventory - Short Form(Baseline, 10-week follow-up, and 14-week follow-up assessments)
- Brief Semi-structured Interview to Assess Acceptability and Feasibility of the Intervention, With Perceived Helpfulness Rating.(Assessed at 10-week follow-up or 14-week follow-up, values at the end of 14 weeks reported)
